AXIM Biotechnologies, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2011 | — | $10.2K | $23.1K |
| FY2012 | — | $-4.7K | $19.1K |
| FY2013 | — | $-93.9K | $127 |
| FY2014 | — | $-580.7K | $661.1K |
| FY2015 | — | $-1.7M | $134.2K |
| FY2016 | — | $-2.4M | $713.3K |
| FY2017 | — | $-6.3M | $2.1M |
| FY2018 | — | $-6.1M | $1.8M |
| FY2019 | — | $-6.8M | $511.6K |
| FY2020 | — | $1.6M | $457.2K |
| FY2021 | — | $-2.3M | $453.0K |
| FY2022 | — | $-4.8M | $47.3K |
| FY2023 | — | $-7.7M | $156.5K |